Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Basis Set Ventures is a San Francisco-based venture capital firm that specializes in early-stage investments in startups leveraging artificial intelligence and automation. Founded in 2017 by Lan Xuezhao, the firm distinguishes itself as an "AI-native" investor, utilizing its own proprietary machine learning stack to source and evaluate deals. The firm's portfolio includes companies across various sectors such as autonomous systems, enterprise software, and specialized AI applications in healthcare and molecular discovery. Basis Set Ventures typically participates in pre-seed, seed, and Series A rounds, providing deep operational support to its founders. As of 2026, the firm manages approximately $850 million in assets across multiple funds.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Basis Set Ventures.